IP Library Granted Patent US 11,666,872
Granted Patent B2
US 11,666,872 · App. 16/659,215 · Granted Jun 6, 2023

Containers for agitation of liquid samples and methods of use thereof

Inventors: Adam Suchocki (Lexington, MA); Mark John Audeh (Brighton, MA); Matthew Blanco (Brookline, MA); James Franklin Chepin (San Diego, CA); Vasiliki Demas (Arlington, MA); Marilyn Lee Fritzemeier (Lexington, MA); Thomas Jay Lowery, Jr. (Belmont, MA); Michael Min (Boston, MA); Lori Anne Neely (Reading, MA); Charles William Rittershaus (Malden, MA); Hwa-Tang Wang (Lexington, MA); Parris Wellman (Reading, MA)
Assignee: T2 Biosystems, Inc.
B01F29/30B01F33/251B01F35/53B01F35/5312B65D1/46C12M47/06C12N1/066C12Q1/686C12Q1/6816G01N27/745G01N33/492B01F2215/0431B65D2221/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,666,872
App. No.
16/659,215
Granted
Jun 6, 2023
Kind
B2
Abstract

The present invention relates to containers for holding liquid samples. The containers may be useful for mixing a liquid sample or lysing cells in a liquid sample. The invention also relates to methods of using the containers of the invention.

Claims (28)

1. A method of lysing cells in a liquid sample, said method comprising:

(a) providing liquid in a container comprising: (i) an interior chamber with a central axis, (ii) a top comprising an opening, and (iii) a substantially circular cross section or a substantially polygonal cross section, wherein the surface of said interior chamber comprises one or more substantially linear protrusions substantially parallel to said central axis, and wherein said liquid comprises rigid particles and cells; and

(b) agitating said liquid in said container,

wherein said agitation is of a sufficient force and duration to lyse said cells.

2. The method of claim 1 , wherein the substantially linear protrusions have a length substantially parallel to said central axis, a depth substantially parallel to the radius of said substantially circular or polygonal cross section, and a width substantially perpendicular to said radius, wherein said depth increases from top to bottom of the substantially linear protrusions and said width increases from top to bottom of the substantially linear protrusions, and wherein the depth of the substantially linear protrusions is greater than 10% of the radius at some point along the length of the substantially linear protrusions.

3. The method of claim 2 , wherein said container comprises a substantially polygonal cross section having a radius, wherein said radius is the distance from said central axis to a corner point, and wherein the surface of said interior chamber additionally comprises one or more substantially linear protrusions substantially parallel to said central axis.

4. The method of claim 2 , wherein said container comprises a substantially polygonal cross section having a radius, wherein said radius is the distance from said central axis to a corner point, and wherein said substantially polygonal cross section is substantially triangular, quadrilateral, pentagonal, hexagonal, heptagonal, octagonal, nonagonal, decagonal, or dodecagonal.

5. The method of claim 1 , wherein said interior chamber comprises 2 to 6 substantially linear protrusions.

6. The method of claim 1 , wherein said rigid particles have a diameter of between 0.1 mm to 1 mm.

7. A method of detecting the presence of a target nucleic acid in a whole blood sample, the method comprising:

(a) providing an extract produced by: (a1) lysing the red blood cells in a whole blood sample from a subject, (a2) centrifuging the sample to form a supernatant and a pellet, (a3) discarding some or all of the supernatant, and (a4) resuspending the pellet to form an extract, wherein the extract comprises one or more additional cells;

(b) lysing said additional cells in said extract, said lysing of said additional cells comprising (b1) combining the extract with rigid particles to form a mixture in a container comprising: (i) an interior chamber with a central axis, (ii) a top comprising an opening, and (iii) a substantially circular cross section or a substantially polygonal cross section, wherein the surface of said interior chamber comprises one or more substantially linear protrusions substantially parallel to said central axis; and (b2) agitating the mixture at a sufficient force and duration to lyse said additional cells, thereby forming a lysate;

(c) providing the lysate of step (b) in a detection tube and amplifying nucleic acids therein to form an amplified lysate solution comprising from 40% (w/w) to 95% (w/w) the target nucleic acid and from 5% (w/w) to 60% (w/w) nontarget nucleic acid; and

(d) detecting the amplified target nucleic acid.

8. The method of claim 7 , wherein the substantially linear protrusions have a length substantially parallel to said central axis, a depth substantially parallel to the radius of said substantially circular or polygonal cross section, and a width substantially perpendicular to said radius, wherein said depth increases from top to bottom of the substantially linear protrusions and said width increases from top to bottom of the substantially linear protrusions, and wherein the depth of the substantially linear protrusions is greater than 10% of the radius at some point along the length of the substantially linear protrusions.

9. The method of claim 8 , wherein said container comprises a substantially polygonal cross section having a radius, wherein said radius is the distance from said central axis to a corner point, and wherein the surface of said interior chamber additionally comprises one or more substantially linear protrusions substantially parallel to said central axis.

10. The method of claim 9 , wherein said container comprises a substantially polygonal cross section having a radius, wherein said radius is the distance from said central axis to a corner point, and wherein said substantially polygonal cross section is substantially triangular, quadrilateral, pentagonal, hexagonal, heptagonal, octagonal, nonagonal, decagonal, or dodecagonal.

11. The method of claim 7 , wherein said interior chamber comprises 2 to 6 substantially linear protrusions.

12. The method of claim 7 , wherein said rigid particles have a diameter of between 0.1 mm to 1 mm.

13. A method of amplifying a target nucleic acid in a whole blood sample, the method comprising:

(a) providing an extract produced by: (a1) lysing the red blood cells in a whole blood sample from a subject, (a2) centrifuging the sample to form a supernatant and a pellet, (a3) discarding some or all of the supernatant, and (a4) resuspending the pellet to form an extract, wherein the extract comprises one or more additional cells;

(b) lysing said additional cells in said extract, said lysing of said additional cells comprising: (b1) combining the extract with rigid particles to form a mixture in a container comprising: (i) an interior chamber with a central axis, (ii) a top comprising an opening, and (iii) a substantially circular cross section or a substantially polygonal cross section, wherein the surface of said interior chamber comprises one or more substantially linear protrusions substantially parallel to said central axis; and (b2) agitating the mixture at a sufficient force and duration to lyse said additional cells, thereby forming a lysate; and

(c) providing the lysate of step (b) in a detection tube and amplifying nucleic acids therein to form an amplified lysate solution comprising from 40% (w/w) to 95% (w/w) the target nucleic acid and from 5% (w/w) to 60% (w/w) nontarget nucleic acid.

14. The method of claim 13 , wherein the substantially linear protrusions have a length substantially parallel to said central axis, a depth substantially parallel to the radius of said substantially circular or polygonal cross section, and a width substantially perpendicular to said radius, wherein said depth increases from top to bottom of the substantially linear protrusions and said width increases from top to bottom of the substantially linear protrusions, and wherein the depth of the substantially linear protrusions is greater than 10% of the radius at some point along the length of the substantially linear protrusions.

15. The method of claim 14 , wherein said container comprises a substantially polygonal cross section having a radius, wherein said radius is the distance from said central axis to a corner point, and wherein the surface of said interior chamber additionally comprises one or more substantially linear protrusions substantially parallel to said central axis.

16. The method of claim 14 , wherein said container comprises a substantially polygonal cross section having a radius, wherein said radius is the distance from said central axis to a corner point, and wherein said substantially polygonal cross section is substantially triangular, quadrilateral, pentagonal, hexagonal, heptagonal, octagonal, nonagonal, decagonal, or dodecagonal.

17. The method of claim 13 , wherein said interior chamber comprises 2 to 6 substantially linear protrusions.

18. The method of claim 13 , wherein said rigid particles have a diameter of between 0.1 mm to 1 mm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2020
From: SUCHOCKI, ADAM; AUDEH, MARK JOHN; BLANCO, MATTHEW; CHEPIN, JAMES FRANKLIN; DEMAS, VASILIKI; FRITZEMEIER, MARILYN LEE; LOWERY, THOMAS JAY, JR.; MIN, MICHAEL; NEELY, LORI ANNE; RITTERSHAUS, CHARLES WILLIAM; WANG, HWA-TANG; WELLMAN, PARRIS S.
To: T2 BIOSYSTEMS, INC.
Reel/Frame 053813/0858 →
Continuity (4)
Continuation 15453356 · Mar 8, 2017
Division 13650734 · Oct 12, 2012
Provisional Application 61601842 · Feb 22, 2012
Related Publication 20200261873A1 · Aug 20, 2020